Pretax income is the income that a company earns before paying income taxes. Bloomage BioTechnology's pretax income for the
three
months ended in Mar. 2025 was ¥133 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥46 Mil.
Bloomage BioTechnology's pretax margin was 12.37%.
During the past 9 years, Bloomage BioTechnology's highest Pretax Margin was 45.00%. The lowest was 0.91%. And the median was 28.83%.
Bloomage BioTechnology Pre-Tax Income Historical Data
The historical data trend for Bloomage BioTechnology's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bloomage BioTechnology's Pre-Tax Income
For the Specialty Chemicals subindustry, Bloomage BioTechnology's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bloomage BioTechnology's Pre-Tax Income Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bloomage BioTechnology's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Bloomage BioTechnology's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology (SHSE:688363) Pre-Tax Income Explanation
Bloomage BioTechnology's Pretax Margin for the quarter that ended in Mar. 2025 is calculated as
During the past 9 years, Bloomage BioTechnology's highest Pretax Margin was 45.00%. The lowest was 0.91%. And the median was 28.83%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Bloomage BioTechnology's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688363 has been successfully added to your 